| 1 |
35533545 | Discovery of a novel GRPR antagonist for protection against cisplatin-induced acute kidney injury. | 2022 Jul |
1 |
| 2 |
34499269 | EGR1-CCL2 Feedback Loop Maintains Epithelial-Mesenchymal Transition of Cisplatin-Resistant Gastric Cancer Cells and Promotes Tumor Angiogenesis. | 2021 Sep 9 |
1 |
| 3 |
32200039 | Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer. | 2020 Jun 1 |
1 |
| 4 |
29231123 | Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy. | 2018 Feb |
1 |
| 5 |
29518977 | Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach. | 2018 Mar 7 |
3 |
| 6 |
28356286 | Early, but not late, treatment with human umbilical cord blood-derived mesenchymal stem cells attenuates cisplatin nephrotoxicity through immunomodulation. | 2017 Oct 1 |
1 |
| 7 |
26124338 | Stimulation by Monocyte Chemoattractant Protein-1 Modulates the Ex-vivo Colony Formation by Head and Neck Squamous Cell Carcinoma Cells. | 2015 Jul |
1 |
| 8 |
26407820 | Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. | 2015 Nov |
2 |
| 9 |
24211271 | Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: impact on NOX-1, inflammation and apoptosis. | 2014 Jan 1 |
1 |
| 10 |
21187454 | CCL2 expression in primary ovarian carcinoma is correlated with chemotherapy response and survival outcomes. | 2010 Dec |
2 |
| 11 |
18697197 | Chemotherapeutic drugs and human tumor cells cytokine network. | 2008 Nov 1 |
1 |
| 12 |
14681721 | hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin. | 2004 Jan |
3 |
| 13 |
10408835 | Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents. | 1999 May |
1 |